University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Hormone Replacement for Premature Ovarian Insufficiency

Phase 3

Withdrawn

Conditions: Primary Ovarian Insufficiency

Interventions: Drug: Combined Oral Contraceptives
Drug: Hormone Replacement Therapy

First Posted Date: 2016-10-04

Last Posted Date: 2019-07-05

Lead Sponsor: University of Pennsylvania

Registration Number: NCT02922348

Locations: 🇺🇸
Penn Fertility Care, Philadelphia, Pennsylvania, United States

Muscle OXPHOS and Nutrient Homeostasis

Active, not recruiting

Conditions: Mitochondrial Diseases
Obesity

Interventions: Other: Tracer-enhanced oral glucose tolerance test (OGTT*)
Other: Muscle MRI
Other: Dual energy x-ray absorptiometry (DXA)
Other: Questionnaires

First Posted Date: 2016-09-30

Last Posted Date: 2023-08-14

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 45

Registration Number: NCT02920671

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Stepping Up For Inflammatory Arthritis

Not Applicable

Completed

Conditions: Arthritis, Rheumatoid
Arthritis, Psoriatic

Interventions: Other: Incentive

First Posted Date: 2016-09-23

Last Posted Date: 2020-12-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 71

Registration Number: NCT02912221

Locations: 🇺🇸
Hospital at the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension

Phase 2

Completed

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: Fulvestrant

First Posted Date: 2016-09-22

Last Posted Date: 2019-12-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT02911844

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Lifestyle Modification and Liraglutide

Phase 4

Completed

Conditions: Obesity

Interventions: Drug: Liraglutide 3.0mg
Behavioral: CMS-recommended lifestyle counseling
Drug: Phentermine 15 MG
Drug: Placebo Oral Tablet
Other: Portion-Controlled Diet
Behavioral: Extension Study CMS-recommended lifestyle counseling

First Posted Date: 2016-09-22

Last Posted Date: 2019-05-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 150

Registration Number: NCT02911818

Locations: 🇺🇸
University of Pennsylvania Center for Weight and Eating Disorders, Philadelphia, Pennsylvania, United States

Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome

Phase 1

Completed

Conditions: Lymphoblastic Leukemia, Acute, Childhood

Interventions: Drug: Tocilizumab
Biological: CART 19

First Posted Date: 2016-09-20

Last Posted Date: 2021-07-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 80

Registration Number: NCT02906371

Locations: 🇺🇸
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Dynamic Presentation of Calorie Information

Not Applicable

Completed

Conditions: Not Condition-specific

Interventions: Other: Item-Level Calorie information
Other: Meal-Level Calorie information

First Posted Date: 2016-09-20

Last Posted Date: 2019-02-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 8544

Registration Number: NCT02906410

Messages and Plans to Increase Gym Utilization

Not Applicable

Completed

Conditions: Body Weight

Interventions: Behavioral: Message

First Posted Date: 2016-09-14

Last Posted Date: 2017-10-31

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1000

Registration Number: NCT02899559

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

[18F]FES PET/CT in PAH

Terminated

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: [18F] FES

First Posted Date: 2016-09-14

Last Posted Date: 2021-05-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT02899533

Locations: 🇺🇸
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

Trans-MAPP II Study of Urologic Chronic Pelvin Pain

Completed

Conditions: Chronic Prostatitis
Interstitial Cystitis

First Posted Date: 2016-09-13

Last Posted Date: 2022-08-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 72

Registration Number: NCT02898220

Locations: 🇺🇸
University of California, Los Angeles (UCLA), Los Angeles, California, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
University of Iowa, Iowa City, Iowa, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy